Burnout: The Framework

Autism research has identified differences in many metabolic pathways, including oxidative stress, glutathione, mitochondrial function, methylation, sulfur metabolism, purine metabolism, and the gut microbiome. These findings do not point to a single cause of autism, but they consistently suggest differences in how the body produces energy, manages metabolic byproducts, and responds to stress.

One pathway appears repeatedly across autism research: purine metabolism.

Purines are more than dietary compounds. They are used to make ATP, the body's energy currency; they act as extracellular danger signals during the stress response; they are recycled to conserve energy; and building new purines requires substantial amounts of folate, amino acids, and ATP. Because of these roles, disturbances in purine metabolism affect energy production, methylation, neurotransmitter synthesis, and cellular repair simultaneously.

This provides one possible explanation for autistic burnout. If the pathway responsible for producing, spending, recycling, and rebuilding energy is under increased metabolic strain, reduced energy availability and increased vulnerability to prolonged stress would be expected outcomes. Burnout, in this framework, is not explained by a single pathway, but purine metabolism occupies a central position because it links energy metabolism with the body's stress response.

A small study identifying reduced expression of MOCOS, a gene involved in activating the molybdenum cofactor, became important because it sits upstream of three pathways repeatedly discussed in autism research:

• Sulfite metabolism
• Aldehyde metabolism
• Purine metabolism

Rather than treating this study as proof of causation, it became an organizing framework. The next question was whether these downstream pathways also appeared independently throughout the autism literature. They do.

Those same pathways also intersect many of the leading biological theories of autism, including oxidative stress, mitochondrial dysfunction, methylation, the Cell Danger Response, gut dysbiosis, neurotransmitter regulation, and immune activation.

The proposed approach

Rather than attempting to force individual pathways to work harder, this framework focuses on reducing the metabolic workload while restoring the resources required to manage that workload.

1. Reduce unnecessary metabolic burden

Many of the compounds discussed throughout this site are normal products of metabolism. The goal is not to eliminate them, but to reduce unnecessary production so that the body's processing systems have less work to do.

The largest controllable sources of metabolic burden discussed here include:

• Chronic stress and persistent fight-or-flight signaling, which increase ATP turnover and purine production.
• Gut dysbiosis, particularly excess lipopolysaccharide (LPS), which promotes inflammation, oxidative stress, gut permeability, and additional production of sulfites, aldehydes, and purines.
• Oxidative stress, which increases reactive oxygen species and lipid-derived aldehydes.
• Environmental sources of aldehydes and sulfites, including cigarette smoke, alcohol, preservatives, and heavily fried foods.

Because LPS represents one of the largest upstream sources of metabolic burden, reducing it is a major focus. This includes rebuilding the gut barrier while also reducing the amount of free LPS available for absorption. The approach described here uses gut binders such as chitosan (preferred) or activated charcoal to bind LPS within the intestine before it crosses the gut wall. Because binders can also bind nutrients, they are used away from meals and supplements.

2. Restore the resources the body depends on

As metabolic demand increases, nutrient demand also increases. Many of the pathways discussed throughout this site rely on the same vitamins, minerals, amino acids, and antioxidants.

The nutrients emphasized include:

• Adequate protein, particularly glycine, glutamine, and aspartate.
• Folate to support purine synthesis and methylation.
• Minerals, especially molybdenum, zinc, magnesium, iron, selenium, and iodine.
• Vitamin B2, which supports FAD-dependent enzymes, glutathione recycling, MTHFR, and xanthine dehydrogenase.
• Vitamin B6 after mineral and B2 status are supported, since B2 is required for its activation and sulfite can inactivate its active form.
• Antioxidant support to maintain glutathione and reduce oxidative damage.

The emphasis is not on taking large doses of individual nutrients, but on restoring the cofactors that multiple pathways depend upon.

3. Focus on the major bottlenecks

Rather than treating every reported metabolic difference as a separate problem, this framework focuses on pathways that influence many others.

The three pathways explored throughout this site are:

• Sulfite metabolism
• Aldehyde metabolism
• Purine metabolism

These were selected because they repeatedly appear throughout the autism literature, intersect many leading biological theories of autism, and all converge on the molybdenum cofactor system.

The overall model

This site does not argue that the molybdenum cofactor explains autism or that every autistic person shares the same metabolic abnormalities.

Instead, it presents a framework for organizing a large body of autism research around pathways that repeatedly appear across independent studies.

The central idea is that burnout may develop when metabolic demand consistently exceeds metabolic capacity. Recovery, therefore, involves working from both directions: reducing unnecessary metabolic burden while restoring the nutrients and cofactors required to process that burden.

Within this framework, purine metabolism provides a biological connection between stress, ATP, folate, and burnout, while the molybdenum cofactor provides a practical way of organizing three major metabolic burdens, sulfites, aldehydes, and purines, that repeatedly emerge throughout the autism literature.